# UK Oncology Information Systems Market

> UK Oncology Information Systems Market Research Report: Size, Share, Trend Analysis By Product Type (Software, Professional Services), By Applications (Medical Oncology, Radiation Oncology, Surgical Oncology) and By End Users (Hospitals & Oncology Clinics, Government Institutes, Research Centers) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.65%
- **2024:** $ 483 Million
- **2025:** $ 519.95 Million
- **2035:** $ 1,087 Million
- **Key Players:** Varian Medical Systems (US), Elekta AB (SE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions (US), IBM Watson Health (US)

**Report ID:** MRFR/Pharma/48650-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/uk-oncology-information-systems-market-50407

---

## Market Summary

## **UK Oncology Information Systems Market Overview**

As per MRFR analysis, the UK Oncology Information Systems Market Size was estimated at 440.25 (USD Million) in 2024.The UK Oncology Information Systems Market Industry is expected to grow from 483(USD Million) in 2025 to 1,029 (USD Million) by 2035. The UK Oncology Information Systems Market CAGR (growth rate) is expected to be around 7.118% during the forecast period (2025 - 2035)

**Key UK Oncology Information Systems Market Trends Highlighted**

The UK Oncology Information Systems Market is experiencing significant trends driven by regulatory support and technological advancements. With the National Health Service (NHS) focusing on digital transformation to improve patient care, there is an increasing emphasis on integrating advanced oncology information systems within healthcare facilities. 

This aligns with the NHS Long Term Plan, which aims to enhance cancer services by utilizing data more effectively for patient management and treatment. Key market drivers include the rising incidence of cancer and the need for efficient management systems to handle patient data and treatment protocols.The push for personalized medicine requires robust data analytics capabilities within oncology information systems, enabling healthcare professionals to tailor treatments based on individual patient profiles. 

Moreover, the implementation of value-based care models in the UK prompts healthcare providers to adopt systems that support tracking outcomes and optimizing resources. Opportunities are emerging in the realm of artificial intelligence and machine learning, which can enhance decision-making, improve treatment planning, and provide predictive analytics for better patient outcomes. 

The continuous evolution of telemedicine and remote monitoring due to the recent focus on patient-centric care offers further chances for system integration and market expansion.Trends in recent times indicate a heightened collaboration between technology firms and healthcare organizations, promoting a streamlined development of oncology systems. 

Additionally, there is a growing engagement from oncology specialists in the refining and customization of these systems, ensuring they meet the clinical requirements specific to the UK. As healthcare in the UK continues to adapt to the demands of modern medicine, the oncology information systems market is poised for growth and transformation, driven by these emerging trends and opportunities.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**UK Oncology Information Systems Market Drivers**

**Increasing Incidence of Cancer Cases**

The increasing incidence of cancer cases in the UK plays a crucial role in driving the growth of the UK Oncology Information Systems Market Industry. According to the latest cancer statistics from Public Health England, nearly 400,000 new cancer cases were diagnosed in the UK in 2020, representing a significant rise compared to previous years.

The rise in cancer cases calls for more effective management solutions, where oncology information systems can help streamline patient data, treatment planning, and clinical workflows.With leading organizations like the National Health Service (NHS) focused on improving cancer care through integrated digital systems, the demand for advanced oncology information systems is set to grow as they enable healthcare professionals to make informed decisions. The urgency for efficient data management in oncology will see a projected increase in the use of these systems in hospitals and cancer treatment centers across the UK, ultimately leading to enhanced patient outcomes and operational efficiencies.

**Government Initiatives and Funding**

Government initiatives aimed at enhancing cancer care in the UK significantly stimulate the growth of the UK Oncology Information Systems Market Industry. The NHS Long Term Plan emphasizes the importance of digital transformation in healthcare, which includes investments in oncology information systems to improve patient care. The UK government allocated substantial funding to support the integration of digital health technologies and improve data management capabilities, recognizing that an efficient oncology information system can enhance early detection and treatment outcomes.

In addition, the Cancer Strategy for England sets out aims for the development of cancer services which includes the promotion of electronic health records and oncology information systems, thus creating a need in this area.

**Technological Advancements in Health IT**

Rapid technological advancements in health information technology are pivotal in propelling the UK Oncology Information Systems Market Industry forward. Innovations such as artificial intelligence (AI), machine learning, and data analytics are being implemented in oncological practices to enhance diagnostic accuracy and treatment personalization. 

A report from NHS Digital states that AI applications in oncology have the potential to increase productivity and efficiency in diagnosis and treatment planning.Leading health technology companies are actively engaging in Research and Development to introduce next-generation oncology information systems, which allow for better integration of patient data and services. These advancements ultimately improve the quality of care and operational efficiency, driving further growth in the oncology information systems market.

**UK Oncology Information Systems Market Segment Insights**

**Oncology Information Systems Market Product Type Insights**

The UK Oncology Information Systems Market exhibits significant growth potential in its Product Type segment, which broadly encompasses Software and Professional Services. This segment plays a critical role in the enhancement of oncology care and management within the UK, which is essential in addressing the rising cancer cases necessitating efficient treatment options and management systems. The demand for advanced software solutions, such as electronic health records and treatment planning systems, has surged in recent years as healthcare providers seek to streamline operations and enhance patient outcomes.

Moreover, the uptake of professional services, which includes consulting, training, and support, has become vital for the successful implementation and ongoing optimization of oncology information systems. These services ensure that healthcare providers can maximize the utility of their software investments while maintaining compliance with evolving healthcare regulations and standards in the UK.

The significance of Software within the Oncology Information Systems Market cannot be understated, as it supports the management of large datasets, patient information, and treatment protocols which are crucial for clinical decision-making. Software innovations are increasingly being leveraged to integrate artificial intelligence and big data analytics, offering insights that were once unattainable and thus driving improved patient care and resource allocation. Similarly, Professional Services are essential in addressing the complexities associated with the deployment of these systems, providing the required expertise to navigate the challenges of interoperability, data security, and user training.

Furthermore, as the healthcare landscape in the UK shifts towards enhanced digitization and value-based care models, there is a growing recognition of the need for robust oncology information systems that can adapt to changing healthcare policies and provide comprehensive analytics that facilitate evidence-based decision-making. This trend toward integrated and patient-centered care reinforces the importance of both Software and Professional Services in supporting healthcare providers to deliver high-quality care while optimizing operational efficiency.

The UK's commitment to advancing its oncology services through the integration of cutting-edge technology and skilled professional support is expected to drive continued growth in this segment of the market, reflecting the broader trend towards digital transformation in the healthcare industry. Overall, the Product Type segment of the UK Oncology Information Systems Market demonstrates a strong trajectory toward innovation, driven by the pressing need for improved cancer care solutions that leverage both advanced software solutions and dedicated professional services for optimal implementation and user adoption.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Oncology Information Systems Market Application Insights**

The UK Oncology Information Systems Market focused on the Application segment comprises vital areas such as Medical Oncology, Radiation Oncology, and Surgical Oncology, each playing a crucial role in patient care and management. Medical Oncology is significant as it encompasses the use of anti-cancer medications and personalized therapies, reflecting the growing trend towards custom treatment plans that cater to individual patient needs.

Radiation Oncology, on the other hand, dominates in offering advanced technologies for targeted radiation treatments, enhancing treatment efficacy while minimizing damage to surrounding tissues.Surgical Oncology remains a cornerstone of cancer treatment, emphasizing the importance of precise surgical interventions to ensure the successful removal of tumors. 

As the UK government continues to invest in health technologies and prioritize cancer care, these Applications are expected to be more integrated within healthcare systems, leading to improved patient outcomes and streamlined workflows. The increasing demand for these services is driven by rising cancer incidence rates and advancements in technology, providing opportunities for market growth and innovation within the Oncology Information Systems landscape.

**Oncology Information Systems Market End User Insights**

The End User segment of the UK Oncology Information Systems Market comprises essential contributors, including Hospitals and Oncology Clinics, Government Institutes, and Research Centers. Hospitals and Oncology Clinics are pivotal in the delivery of cancer care, utilizing advanced information systems to streamline patient management, treatment planning, and data integration to enhance clinical outcomes. Government Institutes play a critical role in healthcare policy implementation and funding for oncology research, ensuring access to innovative treatment solutions for the population.

Research Centers are integral for facilitating groundbreaking advancements in cancer therapies and treatment modalities, supported by sophisticated information systems that aid in data collection and analysis. Together, these entities drive the UK Oncology Information Systems Market, addressing the growing demand for efficient oncology workflows and personalized patient care. Ongoing investments in technology and digitalization further bolster this segment, as healthcare providers prioritize integrated data systems to optimize patient experiences and outcomes, shaping the future landscape of oncology care in the UK.

**UK Oncology Information Systems Market Key Players and Competitive Insights**

The competitive landscape of the UK Oncology Information Systems Market is characterized by rapid advancements in technology and a growing demand for efficient patient management solutions. The market is witnessing a shift towards integrated oncology information systems that not only streamline clinical workflow but also enhance patient care through better data management and analytics. Key players in the market are focusing on developing innovative solutions that incorporate artificial intelligence and machine learning to improve diagnostic accuracy and treatment planning.

The competitive dynamics are influenced by the increasing prevalence of cancer in the UK, coupled with the need for healthcare providers to adopt advanced information systems to optimize their operations and meet regulatory standards. 

As a result, companies are investing heavily in research and development, forging strategic partnerships, and exploring mergers and acquisitions to expand their product offerings and strengthen their market position.Siemens Healthineers holds a prominent position in the UK Oncology Information Systems Market, leveraging its deep expertise in imaging and medical technology to offer comprehensive solutions that support oncologists in patient diagnosis and treatment. The company’s strengths lie in its robust portfolio of imaging equipment coupled with advanced oncology information systems that enable seamless integration of clinical data.

Siemens Healthineers successfully combines innovative technology with clinical insights, facilitating improved patient outcomes through enhanced treatment planning. Its established presence in the UK healthcare sector, bolstered by a reputation for high-quality products and reliable customer support, enables the company to maintain a competitive edge. 

The strong focus on R&D allows Siemens Healthineers to consistently evolve its solutions, catering to the dynamic demands of oncology healthcare providers and ensuring that they remain at the forefront of technological advancements in the market.GenesisCare is a notable player in the UK Oncology Information Systems Market, recognized for its commitment to providing high-quality cancer care through advanced treatment solutions and integrated services. The company has a strong presence in the UK, offering key products such as advanced radiation therapy systems and comprehensive oncology information management systems designed to optimize patient experience and enhance treatment efficacy. 

GenesisCare's strengths lie in its collaborative approach, working closely with healthcare professionals to tailor solutions that meet specific clinical needs. The company has also made strategic investments and acquisitions to expand its capabilities and geographic reach, significantly enhancing its service offerings and market position within the UK oncology landscape. By focusing on cutting-edge technology and evidence-based treatment protocols, GenesisCare continues to strengthen its role in the oncology information systems market, aiming to improve the overall patient journey while maintaining a high standard of care.

**Key Companies in the UK Oncology Information Systems Market Include**

**UK Oncology Information Systems Market Industry Developments**

The UK Oncology Information Systems Market has seen several important developments recently. Siemens Healthineers announced advancements in imaging technology designed to enhance cancer diagnoses as of August 2023, while Elekta launched new software solutions to improve precision treatment planning in July 2023. In the realm of mergers and acquisitions, Oracle Corporation completed its acquisition of Cerner Corporation in June 2023, reinforcing its commitment to health data integration, which is crucial for oncology applications. Additionally, Varian Medical Systems introduced an innovative oncology clinical decision support platform in September 2023, further enriching the market landscape. 

The market valuation for oncology information systems in the UK is expected to grow significantly, with analysts forecasting a robust increase driven by technological advancements and a greater emphasis on personalized medicine. Over the past few years, RaySearch Laboratories has gained traction by entering strategic partnerships in UK healthcare, particularly in collaboration with NHS trusts to streamline treatment processes. There is a growing emphasis on data-driven solutions within oncology, with UK stakeholders increasingly seeking integrated systems that facilitate collaboration among various healthcare entities to improve patient outcomes.

**UK Oncology Information Systems Market Segmentation Insights**

## Market Drivers

### Rising Cancer Incidence

The oncology information-systems market is experiencing growth due to the increasing incidence of cancer in the UK. According to recent statistics, cancer cases are projected to rise by approximately 2.5% annually, leading to a heightened demand for advanced information systems that can manage patient data effectively. This trend necessitates the implementation of sophisticated oncology information systems to streamline treatment processes and enhance patient outcomes. As healthcare providers seek to improve their capabilities in managing cancer care, the oncology information-systems market is likely to expand significantly. The integration of these systems allows for better tracking of patient progress and treatment efficacy, which is crucial in a landscape where timely and accurate data is paramount. Consequently, the rising cancer incidence is a key driver for the oncology information-systems market, pushing for innovation and investment in this sector.

### Technological Advancements

Technological advancements play a pivotal role in shaping the oncology information-systems market. Innovations in data analytics, cloud computing, and machine learning are transforming how healthcare providers manage cancer treatment. For instance, the adoption of cloud-based solutions is expected to increase by over 30% in the coming years, facilitating real-time data access and collaboration among healthcare professionals. These advancements enable more efficient patient management, allowing for personalized treatment plans based on comprehensive data analysis. Furthermore, the integration of telemedicine within oncology information systems is enhancing patient engagement and follow-up care. As technology continues to evolve, the oncology information-systems market is likely to benefit from these developments, leading to improved patient outcomes and operational efficiencies in cancer care.

### Growing Demand for Data Security

Data security concerns are increasingly influencing the oncology information-systems market. With the rise in cyber threats and data breaches, healthcare organizations in the UK are prioritizing the protection of sensitive patient information. The oncology information-systems market is responding to this demand by integrating advanced security features, such as encryption and multi-factor authentication, into their platforms. According to industry reports, nearly 40% of healthcare organizations have experienced a data breach in the past year, underscoring the need for robust security measures. As regulations surrounding data protection become more stringent, the oncology information-systems market is likely to see a surge in demand for solutions that ensure compliance and safeguard patient data. This focus on data security is essential for maintaining trust and integrity within the healthcare system.

### Government Initiatives and Funding

Government initiatives and funding are crucial drivers for the oncology information-systems market. The UK government has committed substantial resources to enhance cancer care, with funding allocations reaching £600 million for cancer services in recent years. This financial support is aimed at improving diagnostic capabilities and treatment options, which directly influences the demand for advanced oncology information systems. By investing in digital health technologies, the government seeks to streamline cancer care processes and improve patient outcomes. Additionally, initiatives promoting the adoption of electronic health records (EHRs) are likely to bolster the oncology information-systems market, as these systems facilitate better data management and interoperability among healthcare providers. As a result, government support is a significant factor driving the growth of the oncology information-systems market.

### Increased Focus on Patient-Centric Care

The oncology information-systems market is increasingly driven by a focus on patient-centric care. Healthcare providers in the UK are prioritizing patient engagement and satisfaction, leading to a demand for systems that enhance communication and support personalized treatment plans. The shift towards patient-centric models is reflected in the growing adoption of oncology information systems that facilitate shared decision-making and provide patients with access to their health data. This trend is likely to continue, as studies indicate that patient involvement in their care can lead to improved treatment adherence and outcomes. Consequently, the emphasis on patient-centric care is shaping the oncology information-systems market, prompting the development of tools that empower patients and enhance their overall experience in cancer treatment.

## Future Outlook

The [Oncology Information Systems Market](https://www.marketresearchfuture.com/reports/oncology-information-systems-market-7080) is projected to grow at a 7.65% CAGR from 2025 to 2035, driven by technological advancements, increasing cancer prevalence, and demand for personalized medicine.

**New opportunities:**

- Integration of AI-driven analytics for treatment optimization. Development of cloud-based oncology data management solutions. Expansion of telehealth platforms for remote patient monitoring.

By 2035, the market is expected to achieve substantial growth, driven by innovation and increasing healthcare demands.

## Segment Insights

### By Product and Service Type: Software (Largest) vs. Professional Services (Fastest-Growing)

The product and service type segment of the UK oncology information-systems market showcases a significant predominance of software solutions, which command the largest share among available options. Software solutions are essential for data management, analytics, and interoperability within healthcare settings, making them a cornerstone of the market. On the other hand, professional services, while smaller in market share, are rapidly gaining traction as they provide essential expertise and support vital for the implementation and optimization of oncology information systems.

Growth trends indicate that the professional services segment is the fastest-growing area, driven by increased demand for specialized consulting and support. Factors contributing to this rise include the growing complexity of oncology data, the need for regulatory compliance, and the push towards personalized medicine, which enables tailored treatment approaches. These trends are creating opportunities for companies that offer both software solutions and professional services, ultimately enhancing patient care and optimizing operational efficiencies.

Software (Dominant) vs. Professional Services (Emerging)

Software solutions in the UK oncology information-systems market are characterized by their comprehensive capabilities in handling vast amounts of patient data, enabling streamlined workflows, and facilitating better decision-making through advanced analytics. This dominant segment benefits from continuous advancements in technology, such as artificial intelligence and cloud computing, which further enhance software functionalities. Conversely, professional services represent an emerging segment that is critical for the successful deployment of software systems. These services encompass consulting, training, and technical support, which are increasingly important as healthcare providers seek to navigate the complexities of oncology data management and improve patient outcomes. As healthcare continues to evolve, the interplay between software and professional services will be vital for achieving operational excellence in oncology care.

### By Application: Medical Oncology (Largest) vs. Surgical Oncology (Fastest-Growing)

In the UK oncology information-systems market, Medical Oncology holds the largest share, leading the application segments due to its extensive usage in cancer treatment protocols and patient management systems. Radiation Oncology ranks closely, while Surgical Oncology, though substantially smaller in share, is showing significant adoption and growth as hospitals seek to integrate advanced technologies into surgical practices.

The growth trends are spurred by technological advancements and increased investments in cancer research. Medical Oncology benefits from strong demand for comprehensive patient care solutions, while Surgical Oncology is experiencing the fastest growth due to the shift towards minimally invasive procedures and the adoption of robotics, enhancing surgery outcomes and efficiencies. Radiation Oncology remains steady as the backbone for treatment regimens but is eclipsed by the rapid advancements in surgery.

Medical Oncology: Dominant vs. Surgical Oncology: Emerging

Medical Oncology stands as the dominant force within the application segments, characterized by its integral role in developing and administering treatment plans. This segment capitalizes on comprehensive data management, with solutions designed for patient tracking, treatment optimization, and drug administration. In contrast, Surgical Oncology is emerging but gaining momentum, characterized by innovation in surgical procedures and techniques. This segment emphasizes a shift towards higher precision surgeries and enhanced patient safety, which is driving demand for integrated information systems that support surgery planning and execution. Both segments highlight the trend towards improved patient outcomes and streamlined operational efficiencies in oncology practices.

### By End-User: Hospitals & Oncology Clinics (Largest) vs. Research Centers (Fastest-Growing)

In the UK oncology information-systems market, Hospitals & Oncology Clinics represent the largest share of the segment, dominating with a significant margin due to their comprehensive service offerings and advanced infrastructure. Government Institutes also hold a notable portion, benefiting from public funding but lag behind the rapidly expanding Research Centers, which are gaining traction through innovation and specialized services.

Growth in this segment is primarily driven by technological advancements and increasing investments in healthcare infrastructure. The demand for personalized medicine and enhanced diagnostic capabilities is fostering rapid growth in Research Centers, while Hospitals & Oncology Clinics continue to thrive due to their established positions and the ongoing need for oncology services. This dynamic creates a competitive landscape that pushes all segments toward improved efficiency and patient outcomes.

Hospitals & Oncology Clinics (Dominant) vs. Research Centers (Emerging)

The Hospitals & Oncology Clinics segment is characterized by its widespread adoption of integrated information systems, focusing on enhancing patient care and operational efficiency. This dominant position is bolstered by their ability to provide comprehensive cancer treatment options, making them essential in the patient care continuum. On the other hand, Research Centers represent an emerging force in the cancer care ecosystem, leveraging cutting-edge technologies and research capabilities to drive innovations in treatment protocols and data management. The increasing collaboration between clinical and research entities is expected to further strengthen the market position of Research Centers, ultimately pushing them towards becoming a significant contributor to the overall growth of the market.

## Competitive Benchmarking

The oncology information-systems market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing cancer prevalence, and a growing emphasis on personalized medicine. Key players such as Varian Medical Systems (US), Elekta AB (SE), and Siemens Healthineers (DE) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Varian Medical Systems (US) focuses on integrating artificial intelligence (AI) into treatment planning, while Elekta AB (SE) emphasizes the development of advanced radiation therapy solutions. Siemens Healthineers (DE) is actively pursuing digital transformation initiatives, which collectively shape a competitive environment that prioritizes technological sophistication and patient-centric solutions.The market structure appears moderately fragmented, with several players vying for market share through localized manufacturing and optimized supply chains. This fragmentation allows for diverse offerings, yet the influence of major companies remains substantial. The collective strategies of these key players indicate a trend towards collaboration and innovation, which is essential for maintaining competitive advantage in a rapidly evolving market.

In October  Varian Medical Systems (US) announced a partnership with a leading UK healthcare provider to implement its latest AI-driven oncology information system. This collaboration aims to enhance treatment accuracy and patient outcomes, reflecting Varian's commitment to integrating cutting-edge technology into clinical practice. Such strategic alliances are likely to bolster Varian's market position and expand its reach within the UK.

In September  Elekta AB (SE) launched a new cloud-based oncology information system designed to streamline data management and improve accessibility for healthcare professionals. This initiative underscores Elekta's focus on digital solutions that enhance operational efficiency and patient care. The introduction of cloud technology may significantly alter the competitive dynamics by enabling more agile responses to market demands.

In August  Siemens Healthineers (DE) unveiled a comprehensive digital platform aimed at integrating various oncology information systems into a unified interface. This strategic move is indicative of Siemens' intent to lead in digital transformation within the oncology sector. By providing a seamless user experience, Siemens may enhance its competitive edge and foster greater collaboration among healthcare providers.

As of November  the oncology information-systems market is witnessing trends such as increased digitalization, sustainability initiatives, and the integration of AI technologies. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident. Moving forward, differentiation will likely hinge on the ability to innovate and deliver superior patient outcomes, positioning companies that prioritize these aspects at the forefront of the market.

## Recent News & Developments

The UK Oncology Information Systems Market has seen several important developments recently. Siemens Healthineers announced advancements in imaging technology designed to enhance cancer diagnoses as of August 2023, while Elekta launched new software solutions to improve precision treatment planning in July 2023. In the realm of mergers and acquisitions, Oracle Corporation completed its acquisition of Cerner Corporation in June 2023, reinforcing its commitment to health data integration, which is crucial for oncology applications. Additionally, Varian Medical Systems introduced an innovative oncology clinical decision support platform in September 2023, further enriching the market landscape. 

The market valuation for oncology information systems in the UK is expected to grow significantly, with analysts forecasting a robust increase driven by technological advancements and a greater emphasis on personalized medicine. Over the past few years, RaySearch Laboratories has gained traction by entering strategic partnerships in UK healthcare, particularly in collaboration with NHS trusts to streamline treatment processes. There is a growing emphasis on data-driven solutions within oncology, with UK stakeholders increasingly seeking integrated systems that facilitate collaboration among various healthcare entities to improve patient outcomes.

## Report Scope

| MARKET SIZE 2024 | 483.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 519.95(USD Million) |
| MARKET SIZE 2035 | 1087.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.65% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Varian Medical Systems (US), Elekta AB (SE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions (US), IBM Watson Health (US) |
| Segments Covered | Product and Service Type, Application, End-User |
| Key Market Opportunities | Integration of artificial intelligence in oncology information-systems enhances patient management and treatment personalization. |
| Key Market Dynamics | Growing demand for integrated oncology information systems driven by regulatory changes and technological advancements in the UK. |
| Countries Covered | UK |

## Frequently Asked Questions

**Q: What was the market valuation of the UK oncology information-systems market in 2024?**
A: The market valuation was $483.0 Million in 2024.

**Q: What is the projected market valuation for the UK oncology information-systems market by 2035?**
A: The projected valuation for 2035 is $1,087.0 Million.

**Q: What is the expected CAGR for the UK oncology information-systems market during the forecast period 2025 - 2035?**
A: The expected CAGR is 7.65% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the UK oncology information-systems market?**
A: Key players include Varian Medical Systems, Elekta AB, Philips Healthcare, Siemens Healthineers, GE Healthcare, Cerner Corporation, McKesson Corporation, Allscripts Healthcare Solutions, and IBM Watson Health.

**Q: What are the main product and service types in the UK oncology information-systems market?**
A: The main product and service types include Software, valued at $650.0 Million, and Professional Services, valued at $437.0 Million.

**Q: How does the market for medical oncology compare to radiation oncology in terms of valuation?**
A: Medical oncology was valued at $350.0 Million, while radiation oncology was valued at $400.0 Million.

**Q: What is the valuation of the surgical oncology segment in the UK oncology information-systems market?**
A: The surgical oncology segment was valued at $337.0 Million.

**Q: Which end-users dominate the UK oncology information-systems market?**
A: Hospitals & Oncology Clinics dominate with a valuation of $680.0 Million, followed by Government Institutes at $200.0 Million.

**Q: What is the valuation range for research centers in the UK oncology information-systems market?**
A: Research centers have a valuation range of $93.0 Million to $207.0 Million.

**Q: How do the valuations of hospitals and oncology clinics compare to government institutes?**
A: Hospitals & Oncology Clinics are valued at $680.0 Million, significantly higher than Government Institutes, which are valued at $200.0 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-oncology-information-systems-market-50407*